What Is Semaglutide? A Quick Overview
You may have heard people talking about Semaglutide recently. It’s getting a lot of attention for helping people…
Aug 26, 20255 min read
Doctor-guided GLP-1 weight care
Book a $0 video or phone consultation with a clinician licensed in your state. If semaglutide or another GLP-1 medicine is right for you, it is delivered within 24 hours, with check-ins as your dose is adjusted.
Monthly plan$299/month, only if prescribed
Limited-time offer: 10% off your plan with code



Is it right for you?
FDA labels for weight-loss GLP-1 medicines cover adults with a BMI of 30 or more, or a BMI of 27 or more with at least one weight-related condition. Use the calculator for a quick check. A licensed clinician makes the final decision.

How it works
No waiting room and no travel. Most people finish the first step in a few minutes.
1Answer a short online health questionnaire about your weight, health history and current medicines.
2Have a free video or phone consultation with a clinician licensed in your state, who decides whether a GLP-1 medicine is safe for you.
3If treatment is prescribed, your medication ships to your door, and your clinician checks in as your dose is adjusted.
Video or phone visitMeet a clinician from home, with no waiting room.
Pick a time that suits youBook online in a few minutes.
A plan made for youYour clinician weighs your history, goals and budget.
Questions answeredMessage our team about your plan or billing.
14.9%
average body weight lost over 68 weeks with semaglutide 2.4 mg in the STEP 1 trial, compared with 2.4% on placebo
Source: Wilding et al., NEJM, 2021. 1,961 adults took part. Individual results vary.
About semaglutide
Semaglutide copies GLP-1, a hormone your gut releases after you eat. It signals fullness to your brain, slows how quickly your stomach empties and helps your body manage blood sugar. Together, those effects make it easier to eat less without constant hunger.
It is taken once a week, starting at a low dose that rises every four weeks. The slow start gives your body time to adjust and reduces side effects such as nausea.
Life on treatment
GLP-1 medicines make healthy changes easier to stick with. Your clinician pairs treatment with practical guidance on eating, protein, activity and sleep.






Photos are illustrative and show models, not patients. Results vary from person to person.
Pricing
Your consultation costs nothing. You only choose a plan if a clinician prescribes treatment.
Limited-time offer: 10% off your plan with code

Monthly plan
$299/month
Billed monthly

3-month plan
$266/month
$799 billed every 3 months

6-month plan
$350/month
$2,100 billed every 6 months
Code HSAVE10 is a limited-time offer and can end at any time. The consultation is free. Plan prices apply only if a clinician prescribes treatment. Monthly figures for multi-month plans are rounded. Prices are set by Semaglutide Medics and can change, so confirm the current price at your consultation.

The video or phone consultation is free. If you are not prescribed treatment, you pay nothing.

Compare options
Both are weekly injectable medicines. Your clinician will help you choose based on your health, goals and budget.

Semaglutide
14.9%
average weight loss, STEP 1

Tirzepatide
20.9%
average weight loss, SURMOUNT-1
| Feature | Semaglutide | Tirzepatide |
|---|---|---|
| Medicine type | GLP-1 receptor agonist | GIP and GLP-1 receptor agonist |
| Brand names | Wegovy (weight), Ozempic (type 2 diabetes) | Zepbound (weight), Mounjaro (type 2 diabetes) |
| How it is taken | Weekly injection, or a daily Wegovy pill approved in December 2025 | Weekly injection |
| Average weight loss in its main trial | 14.9% at 68 weeks (STEP 1, 2.4 mg) | 20.9% at 72 weeks (SURMOUNT-1, 15 mg) |
| Most common side effects | Nausea, diarrhea, vomiting, constipation, stomach pain | Nausea, diarrhea, vomiting, constipation, stomach pain |
Sources: STEP 1, NEJM 2021, SURMOUNT-1, NEJM 2022, FDA Wegovy label, FDA Zepbound label. Trial results are averages from different studies, not a head-to-head comparison; your results may differ.
Safety first
GLP-1 medicines are not right for everyone. Your clinician reviews your history before anything is prescribed.
Tell your clinician about any history of pancreatitis, gallbladder disease, kidney problems or diabetic eye disease.
Based on the FDA prescribing information for Wegovy, which includes a boxed warning about thyroid C-cell tumors.
About compounded semaglutide. Compounded medicines are prepared by licensed pharmacies for individual patients. They are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality. Ask your clinician which medicine you are being prescribed and why. Read the FDA's guidance.

Medically reviewed
Dr. Concetta Green, MD – Board-Certified in Internal Medicine, brings over 12 years of expertise in endocrinology and personalized weight management to help patients achieve lasting health and wellness. Specializing in modern, evidence-based approaches, including GLP-1 medications, Dr. Green guides individuals toward their health goals safely and effectively. Her compassionate care and personalized strategies empower…
Where we treat
Choose your state to see local details and the clinicians who can treat you there.
No state matches that search.
Guides
You may have heard people talking about Semaglutide recently. It’s getting a lot of attention for helping people…
Aug 26, 20255 min read
You have heard about how wonderful semaglutide can be for weight loss. You are excited about the possibilities.…
Sep 2, 20254 min read
Starting a new medication is a big step, and it’s totally normal to have questions about it. Thinking…
Aug 26, 20255 min read
FAQ

Still have questions? Ask a clinician at your free consultation, or email support@semaglutidemedics.org.
Semaglutide is a GLP-1 receptor agonist. It acts like a natural gut hormone that tells your brain you are full, slows how fast your stomach empties and helps control blood sugar. Most people eat less and feel full sooner. It is the active ingredient in Wegovy, which is approved for weight management, and Ozempic, which is approved for type 2 diabetes.
FDA labels cover adults with a BMI of 30 or more, or 27 or more with at least one weight-related condition such as high blood pressure, type 2 diabetes or high cholesterol. A licensed clinician reviews your health history at your consultation and decides whether treatment is safe for you.
In the STEP 1 trial, adults taking semaglutide 2.4 mg once a week with diet and exercise lost an average of 14.9% of their body weight over 68 weeks, compared with 2.4% on placebo. Results vary from person to person, and weight often returns if the medicine is stopped.
The most common side effects are nausea, diarrhea, vomiting, constipation and stomach pain. They are usually mild to moderate and tend to ease as your body adjusts, which is why the dose is raised slowly. Serious but less common risks include pancreatitis, gallbladder problems and low blood sugar in people who also take insulin or sulfonylureas.
No. Compounded medicines are made by a pharmacy for an individual patient and are not FDA-approved, so the FDA does not review them for safety, effectiveness or quality. Your clinician will explain which medicine is being prescribed, where it is made and why it was chosen for you.
The consultation is free. If a clinician prescribes treatment, plans start at $299 a month, with 3-month and 6-month options. You only pay for a plan if treatment is prescribed.
Most patients complete their care online. Semaglutide is not a controlled substance, so a clinician licensed in your state can evaluate you by video where state rules allow. Your clinician may ask for recent lab results or a check-up with your own doctor if needed.
You inject your dose once a week, usually starting low and increasing every four weeks to limit side effects. Your clinician checks in on your progress, side effects and dose, and you can message the support team with questions.